From: Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma
Variable | HR (95% CI) |
---|---|
Gender | |
Male | 1 |
Female | 0.83 (0.47–1.45) |
Age | |
< 66 | 1 |
> 66 | 0.44 (0.23–0.82) |
Stadium | |
I | 1 |
II | 3.10 (0.86–11.25) |
III | 3.11 (0.94–10.32) |
IV | 8.70 (2.90–26.17) |
AC before the target event | |
NO | 1 |
YES | 1,10 (0.49–2.50) |
Mutational status | |
Non exposed | 1 |
EGFR+ | 0.46 (0.23–0.94) |
ALK+ | 0.61 (0.29–1.29) |